Costanzo, A. et al. 2021. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study. Acta Dermato-Venereologica. 101, 10 (Oct. 2021), adv00576. DOI:https://doi.org/10.2340/00015555-3816.